Patient Note — 138311

progress_notes_138311_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID138311 (PHI redacted)
Age / Gender56 / Male
Date of Service2026-04-14
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - National Harbor
PayerHighmark Medicare
Reason1. 2 WK F/U

Diagnoses

C61 Prostate cancer
R97.20 Elevated prostate specific antigen [PSA]
S06.890A Other specified intracranial injury without loss of consciousness, initial encounter

Medications

Fluticasone Furoate Rosuvastatin Calcium , Notes to Pharmacist: Abilify , Notes to Pharmacist: DULoxetine HCl , Notes to Pharmacist: dilTIAZem HCl , Notes to Pharmacist: Cefuroxime Axetil Discontinued levoFLOXacin Progress Note: [PROVIDER_NAME], MD 04/14/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/15/2026 02:30 PM EDT 1/4 4/15/26, 11:30 AM Print Preview [PATIENT_NAME] DOB: [DOB] (56 yo M) Acc No. [ACCOUNT_ID] DOS: 04/14/2026 Medication List reviewed and reconciled with the patient

Past Medical History

  • Brain injury
  • Ptsd
  • Pre diabetic
  • High liver enzymes
  • Depression

Vitals

RR 16.0
HR 73.0
BP 101/74
BMI 24.39
WEIGHT 170 lbs
HEIGHT_IN 70.0

Clinical Summary (HPI)

Elevated PSA/Screening: 56yM with elevated PSA presents for biopsy review History: Flow is good. Nocturia 1-2. No dysuria or gross hematuria. No prostate meds. History of TBI secondary to fall 2020. --------------- The patient's previous work-up history is listed below: PSA: 5.8 (Nov 2025) Prostate MRI (Feb 2026): Prostate measures 3.7 x 2.6 x 4.8 cm with a calculated volume of 24 cc. PI-RADS 4 left peripheral zone lesion. No evidence for extracapsular extension. (Independently reviewed the actual images/tracings and came to my own conclusions) FamHx: negative for prostate cancer. Prostate Cancer (localized): Prostate Bx information Date of biopsy 03-2026 Fusion biopsy? Yes Gleason Score (all positives) 3+4=7 (Grade Group 2) Total cores positive (not including fusion) #1: Gleason 3+4=7, #2: Gleason 3+4=7, #4: Gleason 3+4=7 Largest % core involvement 60

Raw Note (de-identified preview)

4/15/26, 11:30 AM Print Preview [PATIENT_NAME] DOB: [DOB] (56 yo M) Acc No. [ACCOUNT_ID] DOS: 04/14/2026 [PATIENT_NAME] 56 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Highmark Medicare PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - National Harbor 04/14/2026 Prostate bx fu: [PROVIDER_NAME], MD Reason for Appointment 1. 2 WK F/U History of Present Illness Elevated PSA/Screening: 56yM with elevated PSA presents for biopsy review History: Flow is good. Nocturia 1-2. No dysuria or gross hematuria. No prostate meds. History of TBI secondary to fall 2020. --------------- The patient's previous work-up history is listed below: PSA: 5.8 (Nov 2025) Prostate MRI (Feb 2026): Prostate measures 3.7 x 2.6 x 4.8 cm with a calculated volume of 24 cc. PI-RADS 4 left peripheral zone lesion. No evidence for extracapsular extension. (Independently reviewed the actual images/tracings and came to my own conclusions) FamHx: negative for prostate cancer. Prostate Cancer (localized): Prostate Bx information Date of biopsy 03-2026 Fusion biopsy? Yes Gleason Score (all positives) 3+4=7 (Grade Group 2) Total cores positive (not including fusion) #1: Gleason 3+4=7, #2: Gleason 3+4=7, #4: Gleason 3+4=7 Largest % core involvement 60 Current Medications Taking Fluticasone Furoate Rosuvastatin Calcium , Notes to Pharmacist: 20mg Abilify , Notes to Pharmacist: 2mg DULoxetine HCl , Notes to Pharmacist: 20mg dilTIAZem HCl , Notes to Pharmacist: 120mg Cefuroxime Axetil 500 MG Tablet TAKE 1 TABLET (500 MG) BY MOUTH TWICE A DAY FOR 14 DAYS Oral Discontinued levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure Progress Note: [PROVIDER_NAME], MD 04/14/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/15/2026 02:30 PM EDT 1/4 4/15/26, 11:30 AM Print Preview [PATIENT_NAME] DOB: [DOB] (56 yo M) Acc No. [ACCOUNT_ID] DOS: 04/14/2026 levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure Medication List reviewed and reconciled with the patient Past Medical History Brain injury. Ptsd. Pre diabetic. High liver enzymes. Depression. Surgical History craniectomy, cranial plasty 5 yrs ago colonoscsopy 2yrs ago Family History Father: deceased, liver problems, possible colon or prostate cancer (unsure) Mother: deceased, heart attack Social History Smoking: no Recreational drug use: no. Exercise: yes. Caffeine: no. Sexually active: yes. Tobacco Control (Standard) Tobacco use: Nonsmoker Screening Allergies Amoxicillin Hospitalization/Major Diagnostic Procedure inova/infection,acute prostatis 4/1-4/2026 Review of Systems 11 system Review